AARD Financial Statements & SEC Balance Sheet

$5.27

+0.00(+0.00%)

⏱️ End-of-day dataAs of Oct 1, 2026

Historical 2-Year Statements

Financial Metric / Line Item	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024
Fiscal Date	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Period	quarterly	quarterly	quarterly	quarterly	quarterly	quarterly
Year	2,026.00	2,025.00	2,025.00	2,025.00	2,025.00	2,024.00
Cash And Cash Equivalents	$62.44M	$47.05M	$39.28M	$26.00M	N/A	N/A
Other Short Term Investments	$28.76M	$62.98M	$87.06M	$11.58M	N/A	N/A
Other Current Assets	$2.38M	$1.86M	$2.86M	$2.95M	N/A	N/A
Total Current Assets	$93.58M	$11.19M	$12.92M	$14.48M	N/A	N/A
Properties	269,000.00	355,000.00	439,000.00	522,000.00	N/A	N/A
Other Non Current Assets	$4.74M	$4.94M	$3.58M	$2.19M	N/A	N/A
Total Non Current Assets	$5.01M	$5.29M	$4.02M	$2.71M	N/A	N/A
Total Assets	$98.59M	$11.72M	$13.32M	$14.75M	N/A	N/A
Accounts Payable	$4.49M	$2.07M	$4.44M	$5.06M	N/A	N/A
Accrued Expenses	$5.26M	$5.12M	$3.71M	$3.46M	N/A	N/A
Short Term Debt	336,000.00	441,000.00	429,000.00	417,000.00	N/A	N/A
Pensions	$1.52M	$2.91M	$2.15M	$1.38M	N/A	N/A
Total Current Liabilities	$11.60M	$10.55M	$10.74M	$10.31M	N/A	N/A
Total Non Current Liabilities	0.00	0.00	116,000.00	240,000.00	N/A	N/A
Total Liabilities	$11.60M	$10.55M	$10.85M	$10.55M	N/A	N/A
Common Stock	0.00	0.00	0.00	0.00	N/A	N/A
Retained Earnings	$-13.75M	$-11.59M	$-98.32M	$-82.00M	N/A	N/A
Other Shareholders Equity	14,000.00	81,000.00	82,000.00	-3,000.00	N/A	N/A
Total Shareholders Equity	$86.99M	$10.66M	$12.24M	$13.69M	N/A	N/A
Additional Paid In Capital	$22.45M	$22.25M	$22.06M	$21.89M	N/A	N/A
Deferred Revenue	N/A	0.00	0.00	0.00	0.00	671,000.00
Long Term Debt	N/A	0.00	116,000.00	228,000.00	N/A	N/A
Other Non Current Liabilities	N/A	N/A	N/A	12,000.00	N/A	N/A

AARD — Aardvark Therapeutics, Inc. Common Stock